Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02946294Phase 2Completed
Phase 2, randomised, single-blind trial of bupivacaine in postoperative pain, sponsored by Cairo University. Primary endpoints: Intraoperative fentanyl consumption and Total morphine consumption at 24 hours. Started Oct 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02946294.